Multiple sclerosis in children under 10 years of age.
Despite the consistent amount of information accumulated in recent years on multiple sclerosis (MS) in childhood, many clinicians still view this condition as an exclusively young adult-onset disease and do not consider that it may occur and manifest even during infancy and pre-school age, suggesting that the number of MS cases in the paediatric age group may have been underestimated. Thus, the need to have practical parameters for therapeutic, counselling and educational purposes in such settings as caring for patients whose onset of disease is at very early ages may increasingly arise for practising clinicians. In addition, the clinical and radiographic criteria for the diagnosis of MS have not been validated in a paediatric MS population; accordingly, inclusion age at onset (such as for research purposes) is generally over 10 years. To highlight the peculiarities that characterise MS when it begins at this young age we have reviewed the literature and summarised our preliminary results with the national registry of the Italian Society of Paediatric Neurology (SINP) Study Group on Childhood MS in the group of MS patients with the earliest onset of disease (i.e., <10 years of age).
Ruggieri
M
M
Institute of Neurological Science, National Research Council, Viale R. Margherita 6, I-95125 Catania, Italy. m.ruggieri@isn.cnr.it
Iannetti
P
P
Polizzi
A
A
Pavone
L
L
Grimaldi
L M E
LM
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D017668:Age of Onset; D002648:Child; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D009103:Multiple Sclerosis / Q000453:epidemiology* / Q000473:pathology* / Q000503:physiopathology / Q000517:prevention & control; D010455:Peptides; D015203:Reproducibility of Results; D012196:Review Literature as Topic; D012737:Sex Factors
D010455:Peptides; C009049:progressin